World Vaccine Congress Lyon 2010
Date: 2010-10-04 - 2010-10-07
Time: 09:00 - 05:00
Event Type: Conference
Event Organizer: Terrapinn
Contact Person: Paul Gilbertson Send Enquiry
Country: France
Region/Province/State: -NA-
Venue: Lyon
URL: http://www.terrapinn.com/2010/wvcl
Language: English
Target Participant(s): Pharma / Vaccine Manufacturer
Biotech
Academia / Research
Venture Capital
Contract Research Organisation
Contract Manufacture Organisation
Equipment / Technology Provider
Drug Delivery
Clinical Trial Sites
Industry Sector(s): Health & Personal Care
Medical, Pharmaceutical & Herbal
Descriptions:
Innovation and opportunity for pharma, biotechs, healthcare and investors

The 12th annual World Vaccine Congress Lyon is Europe's largest and most influential event addressing the scientific and strategic opportunities, challenges and latest developments that affect the success of your research, your candidates and your business.

* Expect to do business with over 250 senior executives over 4 days
* Bring home an extensive list of business leads and close the deal that you have been aiming for
* Find out how your peers and competitors are achieving business success


2010 key speakers include:

* Dr Robin Robinson, Director, BARDA and Assistant Deputy Secretary, Office of the ASPR, US DHHS
* Dr Ole Olesen, Scientific Officer, Neglected Infectious Diseases, Infectious Diseases Unit DG-Research, European Commission
* Dr Jeffrey Almond, Vice President, Discovery and External Research and Development, sanofi pasteur
* Dr Christian Mandl, Vice President, Global Head of Virology, Head Research, US, Novartis Vaccines and Diagnostics
* Pierre Morgon, Vice President, Franchise and Global Marketing Operations, sanofi pasteur
* Jeffrey Hackman, Senior Vice President Commercial Operations, Intercell
* Dr Ludo Lauwers, Senior Vice President, Beerse R&D Site Manager, Johnson & Johnson Pharmaceuticals
* Dr Maria Allende, Medical Director, Clinical Development, Vaccines, Baxter BioScience
* Dr Jean Lang, Associated Vice President, Research and Development, Dengue Vaccine Program Head, sanofi pasteur
* G S Reddy, Chief General Manager, Indian Immunologicals

Please visit the website for full programme and speaker details. http://www.terrapinn.com/vaccinelyon
No. of Visits: 417
enquiry   forward   print   report
back